Drug intelligence / Profile preview

Olopatadine + azelastine

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Ophthalmic, Intranasal
01

Overview

Olopatadine + azelastine is a combination of two antihistamine drugs used primarily for the treatment of allergic conditions such as allergic rhinitis and conjunctivitis. Both agents are selective histamine H1 receptor antagonists that block the action of histamine released during allergic reactions. Olopatadine is commonly available as an ophthalmic solution (eye drops) for treating ocular symptoms like itching and redness due to allergies[1][5][6]. Azelastine is typically formulated as a nasal spray to relieve nasal symptoms such as congestion, sneezing, and runny nose associated with seasonal or perennial allergic rhinitis[3][4][7]. Both drugs have rapid onset of action and are well tolerated. They may be used individually or in combination with other therapies for enhanced symptom control in moderate-to-severe cases[3].

02

Targets

HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Olopatadine + azelastine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olopatadine + azelastine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call